Document Details
Form
Filing Date
Sep 24, 2026
Document Date
Sep 24, 2026
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
ADARx Pharmaceuticals
Issuer
ADARx Pharmaceuticals, Inc.